Table 6.
EPIAO®/EPREX® treatment for 6 mo and baseline hemoglobin level.
| EPIAO® (N = 82) | EPREX® (N = 84) | P value | 95% CI | |||||
|---|---|---|---|---|---|---|---|---|
| Index | Baseline | 6 mo | Difference | Baseline | 6 mo | Difference | Confidence interval | |
| Hemoglobin (g/dL) | ||||||||
| Mean (SD) | 11.19 (0.57) | 11.13 (0.89) | −0.06 (1.01) | 11.26 (0.55) | 11.11 (0.95) | −0.15 (0.97) | ||
| Median (Q1~Q3) |
11.25 (10.7~11.7) |
11.10 (10.60~11.72) |
−0.10 (-0.52~0.62) |
11.25 (10.8~11.8) |
11.3 (10.52~11.7) |
−0.1 (-0.7~0.6) |
||
| Min~Max | 10~12.3 | 9.4~14.5 | −3.1~3.0 | 10.1~12.4 | 8.3~13.4 | −3~2.2 | ||
| Hemoglobin level difference | .71 | 0.05 (−0.22, 0.33) | ||||||